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CorrespondenceCardiomyocyte Cell-Cycle
Activity during PreadolescenceEarlier studies (Soonpaa et al., 1996)
revealed a rapid drop-off of ventricular
cardiomyocyte cell-cycle activity at birth
in mice, followed by a burst of DNA syn-
thesis during the first week of postnatal
life which contributed to the formation of
multi-nucleated cardiomyocytes by post-
natal day 10 (PN10). It has recently been
suggested that a second burst of cardio-
myocyte cell-cycle activity occurs dur-
ing preadolescence, between PN14 and
PN18, resulting in a 40% increase in car-
diomyocyte number (Naqvi et al., 2014).
Since there was no overt change in
mono- versus bi-nuclear cardiomyocytecontent and no change in cardiomyocyte
nuclear ploidy between PN14 and PN18,
a 40% increase in ventricular cardiomyo-
cyte number during preadolescence
should result in newly synthesized DNA
in 57% of the cardiomyocyte nuclei.
To characterize this putative burst of
preadolescent cell-cycle activity, MHC-
nLACmice, expressing a nuclear-localized
b-galactosidase reporter in cardiomyo-
cytes and maintained in a DBA/2J back-
ground (Soonpaa et al., 1994), were
implanted with BrdU-containing osmotic
mini-pumps. Cumulative ventricular cardi-
omyocyte DNA synthesis was quantitatedCell 163,by co-localization of b-galactosidase and
BrdU immune reactivity (Figure 1A) as
described (Reuter et al., 2014). Only low
levels of cardiomyocyte DNA synthesis
were detected in mice carrying pumps
from PN10 through PN19 (2.96% ±
0.55%) or from PN12 through PN19
(1.09% ± 0.33%; see also Table S1A).
BrdU was detected in small intestine crypt
cells by 24 hr postimplantation, and at the
end of the labeling period (Figure 1B), con-
firming continuous infusion. Cumulative
preadolescent cardiomyocyte DNA syn-
thesis was also quantitated in C57Bl/6J
inbred mice (the strain used by Naqvi and
colleagues); S-phase cardiomyocytes
were identified by nuclear BrdU immune
reactivity in dispersed cell preparations
(Figure 1C). Only low rates of cardiomyo-
cyte DNA synthesis were detected (Ta-
ble S1B). Mice receiving a single BrdU
injection on PN14.5, PN15, or PN16 and
analyzed on PN19 also had little labeling
(Table S1C), arguing that BrdU cytotoxicity
and/or the presence of the osmotic mini-
pumpper sewerenot confounding factors.Figure 1. Characterization of Car-
diomyocyte Cell-Cycle Parameters during
Preadolesence
(A) Example of cardiomyocyte DNA synthesis
(arrow) in the heart of an MHC-nLAC mouse car-
rying a BrdU mini-pump from PN10 through PN19.
Panels showHoechst staining of DNA (blue signal),
beta-galactosidase immune reactivity (red signal)
and BrdU immune reactivity (green signal). Scale
bar, 10 microns.
(B) BrdU immune reactivity (green signal) in the
small intestine of an MHC-nLAC mouse carrying a
BrdU mini-pump for 24 hr (left) or 9 days (right).
Arrows, villi crypts. Scale bar, 200 microns.
(C) Example of cardiomyocyte DNA synthesis
(arrow) in dispersed cells from a C57Bl/6J mouse
heart carrying a BrdU mini-pump from PN10
through PN19. Panels show Hoechst staining of
DNA (blue signal) and BrdU immune reactivity
(green signal). Scale bar, 20 microns.
(D) Example of an S-phase cardiomyocyte nucleus
in a PN15 heart as evidenced by co-localization of
Nkx2.5 (red signal) and Ki-67 (green signal) im-
mune reactivity (arrow). Scale bar, 10 microns.
(E) Example of cardiomyocyte (upper panel) and
non-cardiomyocyte (lower panel) H3P immune
reactivity (green signal, arrow) in postnatal hearts.
Cardiomyocytes were identified by a-actinin im-
mune reactivity (red signal). Scale bar, 10 microns.
(F) Cardiac expression of mitosis-related genes on
PN10, PN14, PN15, PN16, and PN21 in C57BL/6J
mice (mean ± SEM) relative to their level at P10.
mRNA levels were quantitated and normalized to
18S as described (Livak and Schmittgen, 2001).
Significance was tested using unpaired, 2-tailed
Student’s t tests with Bonferroni correction for
multiple testing; bars indicate p < 0.05 versus
subsequent time point.
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Cardiomyocyte cell-cycle activity was
also quantitated via co-localization of
Nkx2.5 and Ki-67 immune reactivity
(Figure 1D); Ki-67 is expressed from G1
phase to anaphase and thus provides a
very good estimate of the fraction of a
given cell population with cell-cycle activ-
ity (Lopez et al., 1994). The cardiomyocyte
nuclear Ki-67 labeling never exceeded
1% in C57Bl/6J ventricles between
PN12 and PN16 (Table S1D), in agree-
ment with the BrdU incorporation data.
Phosphorylation of histone H3 on serine
10 (H3P), which labels cells from G2/M
through early anaphase (Hendzel et al.,
1997), was also used to monitor cardio-
myocyte cell-cycle activity. Since cardio-
myocyte mitosis is characterized by
sarcomere disassembly (Engel et al.,
2006), mitotic ventricular cardiomyocytes
can be identified by the presence of H3P
signal and sarcomere disassembly
(Figure 1E). No mitotic cardiomyocytes
were observed after PN12 (Table S1E).
Ventricular expression levels of a panel
of mitosis-related genes (encoding anilin,
aurora A, polo-like kinase 1, survivin, cy-
clin B1, and Ki-67) were measured by
qPCR in C57Bl/6J mice, and the relative
levels of expression were normalized to
that of 18S rRNA as described (Liu et al.,
2015). No changes in transcript levels
supporting the presence of a proliferative
burst between PN14 and PN16 were de-
tected (Figure 1F). Collectively, the low
rates of cardiomyocyte DNA synthesis
(analyzed by M.H.S. and L.J.F.), the low
levels of cardiomyocyte Ki-67 and H3P
immune reactivity (analyzed by D.C.Z.
and F.B.E.) and the absence of transient
increases in mitotic transcripts (analyzed
by C.P and A.R.) during preadolescence
are consistent with the pattern of gradual
postnatal ventricular cardiomyocyte cell-
cycle withdrawal reported earlier using
single injections of tritiated thymidine to782 Cell 163, November 5, 2015 ª2015 Elsevmonitor cardiomyocyte cell-cycle activity
(Soonpaa et al., 1996).
Potentially trivial factors such as the
method for defining postnatal age, strain
differences, BrdU cytotoxicity, cell identi-
fication in histologic samples, and the se-
quences of the PCR primers used, were
controlled for and thus cannot explain
the differences in the results presented
here and those of Naqvi and colleagues.
Whether subtle differences in animal hus-
bandry can explain the differences in the
measured parameters between the two
studies remains unclear and worthy of
further investigation. Indeed, the current
study does not rule out the possibility
that a preadolescent burst in cardiomyo-
cyte cell-cycle activity can exist,
assuming that as of yet undefined optimal
conditions of litter size, nutrients, etc., are
met. However, the data presented here
clearly indicate that preadolescent devel-
opment did occur in the absence of a
burst of cardiomyocyte proliferation over
multiple litters in three independent
breeding colonies. Consequently, a burst
of preadolescent cell-cycle activity is not
required for normal cardiac development.
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